Savara Inc.

Healthcare

NASDAQ:SVRA · NASDAQ Global Select

Market Cap $1.10B Beta 0.27 P/E (TTM) -10.6

$5.50 +0.46%

+$0.03 today

52W Low $1.98High $7.01

Vol 3.57M · Avg 1.53M

EPS (TTM) -$0.51Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+154.63%

Period High

$6.94

Period Low

$2.05

Latest

$5.50

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tango Therapeutics, Inc.

NASDAQ:TNGX

$3.55B

Nanobiotix S.A.

NASDAQ:NBTX

$1.78B

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.67B

GH Research PLC

NASDAQ:GHRS

$1.48B

Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

$1.25B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.12B

Kura Oncology, Inc.

NASDAQ:KURA

$854.90M

Geron Corporation

NASDAQ:GERN

$821.15M

Rezolute, Inc.

NASDAQ:RZLT

$487.72M

ProKidney Corp.

NASDAQ:PROK

$261.50M

What is the latest SVRA filing?

The latest filing shown is 8-K dated Jun 8, 2026.

How many recent filings does SVRA have?

Intrinsic Alpha currently shows 20 recent filings for SVRA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.